[THE SIGNIFICANCE OF PROTEOLYSIS IN OBSTETRICAL DEFIBRINATION HEMORRHAGES AND THERAPY WITH TRASYLOL].
D000347:Afibrinogenemia; D000653:Amniotic Fluid; D007611:Aprotinin; D001796:Blood Protein Disorders; D001797:Blood Protein Electrophoresis; D004617:Embolism; D004619:Embolism, Amniotic Fluid; D004791:Enzyme Inhibitors; D005260:Female; D005313:Fetal Death; D005341:Fibrinolysin; D005342:Fibrinolysis; D006470:Hemorrhage; D006801:Humans; D007120:Immunochemistry; D007610:Kallikreins; D010920:Placenta; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D059748:Proteolysis; D014357:Trypsin
D004791:Enzyme Inhibitors; D007611:Aprotinin; D007610:Kallikreins; D014357:Trypsin; D005341:Fibrinolysin
AFIBRINOGENEMIA; BLOOD PROTEIN DISORDERS; BLOOD PROTEIN ELECTROPHORESIS; EMBOLISM, AMNIOTIC FLUID; ENZYME INHIBITORS; FETAL DEATH; FIBRINOLYSIN; FIBRINOLYSIS; IMMUNOCHEMISTRY; KALLIKREIN; KALLIKREIN-TRYPSIN INACTIVATOR; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; TRYPSIN
DIE BEDEUTUNG DER PROTEOLYSE BEI GEBURTSHILFLICHEN DEFIBRINIERUNGSBLUTUNGEN UND DIE THERAPIE MIT TRASYLOL.